期刊文献+

绵阳市228例艾滋病感染者和病人CD4^+T淋巴细胞检测分析 被引量:8

Detection of CD4^+T lymphocytes from 228 HIVcarriers and AIDS patients in Mianyang city,Sichuan province
原文传递
导出
摘要 目的检测HIV感染者或病人CD4+T淋巴细胞,了解免疫重建时机,分析检测的影响因素。方法对绵阳市2007~2010年艾滋病感染者或病人共228例用贝克曼流式细胞仪按《全国艾滋病防治规划》要求进行CD4+T淋巴细胞检测,并对经静脉吸毒传染者、男男同性接触传染和异型性接触传染三类人群CD4+T淋巴细胞进行分析。结果接受HAART的病人63.2%以上免疫重建较好;三类人群CD4+T淋巴细胞计数比较存在差异。结论当CD4+T细胞计数较高(>200个/μl或>350个/μl)时接受抗病毒治疗免疫重建较好;CD4+T淋巴细胞计数较低和变化幅度较大时,临床医生应结合病毒载量及临床症状综合分析。 Objective To analyze CD4 + T lymphocytes in 228 HIV carriers and AIDS patients.Methods The CD4 + T lymphocytes in 228 HIV/AIDS patients in Mianyang city were detected using BeckMan flow cytometry from 2007 to 2010 according to the national AIDS control program.Meantime the CD4 + T lymphocytes in drug users through intravenous injection,male homosexuals and heterosexuals were also detected.Results The immune reconstruction of over 63.2% patients treated with HAART were relatively good,but the lymphocyte counts in the drug suers,male homosexuals and heterosexuals were different associated with a number of factors.Conclusions The immune reconstitution might be good when the HIV/AIDS patients accepting antiviral treatment and the level of CD4 + T cells was high(200 个 /μl or 350 个 /μl).The clinicians should take the viral load into consideration in case the levels of CD4 + T lymphocytes was low or varied greatly.
出处 《中国热带医学》 CAS 2013年第3期335-336,342,共3页 China Tropical Medicine
关键词 CD4+T细胞计数 艾滋病感染者或病人 免疫重建 Count of CD4+T cell HIV carriers AIDS patients Immune reconstitution
  • 相关文献

参考文献4

  • 1吴东昌,孙启盛,袁晓雷,等.全国艾滋病检测工作管理办法[M],北京:中国中医药出版社,2006,7,124.
  • 2Grabar S,le Moing V,Goujard C,et al . Clinical outcome of patientswith HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy J] . Ann Intern Med,2000,133(6) :401-410.
  • 3曹韵贞,梅珊,李莉,阴宁,李关汉,魏非力,王福生.抗艾滋病病毒治疗进展[J].中国性病艾滋病防治,2002,8(5):310-314. 被引量:12
  • 4赵红心,张福杰.中西医结合治疗艾滋病的机遇与挑战[J].中国艾滋病性病,2008,14(4):425-427. 被引量:9

二级参考文献29

  • 1王健,刘颖.中医药治疗艾滋病的现状及展望[J].科技导报,2005,23(7):29-33. 被引量:26
  • 2赵红心,张福杰,韩宁,兰孟东,姚均,刘志英,卢联合,魏红山.高效抗逆转录病毒治疗间断过程中中药对CD4+T淋巴细胞和病毒载量的影响[J].中国医学科学院学报,2006,28(5):658-661. 被引量:11
  • 3Fischl MA, Richman DD, Grieco MH, et al.The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex.A double-blind, placebo-controlled tria[ J ]. N Engl J Med, 1987,317(4):185 - 191.
  • 4Fischl MA, Richman DD, Hansen N, et al. The safety and efficacy of zidovudine(AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV)infection. A doubleblind, placebo-controlled trial.The AIDS Clinical Trials Group [ J]. Ann Intern Med, 1990,112(10) : 727 - 737.
  • 5Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals.Delta Coordinating Committee [ J ]. Lancet, 1996,348 (9023) : 283 - 291.
  • 6Schooley RT, Ramirez-Ronda C, Lange JM, et al.Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy. Wellcome Resistance Study Collaborative Group[J]. J Infect Dis, 1996,173(6) : 1354 - 1366.
  • 7Chun TW, Fauei AS. Latent reservoris of HIV: obstacles to the eradication of virus[J]. Proc Natl Acad Sci U S A, 1999,96(20) : 10958 - 10961.
  • 8Chun TW, Davey RT, Engel D, et al. Re- emergence of HIV after stopping therapy [ J ]. Nature, 1999,401 (6756) : 874 - 875.
  • 9Marzolini C, Telenti A, Decosterd LA, et al.Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV infected patients[ J ]. AIDS, 2001,13 : 71 - 75.
  • 10Brinkman Kter, Hofstede H J, Burger D M, et al. Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway[J]. AIDS, 1998,12 : 1735 - 1744.

共引文献19

同被引文献72

  • 1姜楠,薛晓玲.无症状期艾滋病HIV感染者CD_4^+ CD_8^+T淋巴细胞检测结果分析[J].医药论坛杂志,2005,26(13):1-2. 被引量:4
  • 2张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:105
  • 3郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 4兰青,韦嘉.人类免疫缺陷病毒/艾滋病合并乙型肝炎病毒感染的研究[D].昆明市:昆明医学院,2011.
  • 5张福杰.国家免费艾滋病抗病毒治疗手册[M].第3版.北京:人民卫生出版社,2012:141.
  • 6Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China na- tional free antiretroviral treatment program [ J]. Annlntem Med, 2009,151 (4) :241-251.
  • 7Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-l-in- fected patients in the first year of antiretroviral therapy : comparison between low-come and high-income countries [ J]. Lancet, 2006, 367(9513) :817-824.
  • 8Grabar S, Le Moing V, Goujard C, et al. Clinical outcome of pa- tients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy [ J ]. Ann Intern Med, 2000,133(6) :401-410.
  • 9Cuong do D, Thorson A, Sonnerborg A, et al. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam [ J ]. Scand J Infect Dis, 2012,44 ( 3 ) : 201-208.
  • 10Alencar WK, Duarte PS, Waldman EA, et al. Survival analysis of acquired immune deficiency syndromepatients with and without hep- atitis C virus infection at areference center for sexually transmitted diseases/acquiredimmune deficiency syndrome in Sao Paulo, Brazil [J]. BrazJInfect Dis, 2014,18(2) :150-157.

引证文献8

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部